Giordano Christopher Thomas
Transaction: 07/13/2026
BUY
Change
+219
Price
$3.55
Filing
07/14/2026
Type
BUY
Tenax Therapeutics, Inc.
TENX • Biotechnology
$1.94
▲ +0.16 (+8.99%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$98.69M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 14.56Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 1:03 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$1.94
Change8.99%
Shares Out50.87M
Market Cap$98.69M
Enterprise Value$-19.29M
52W Range1.31 - 19.40
Beta0.93
P/E-1.52
P/B0.87
P/FCF-2.14
EV/EBITDA0.29
EV/FCF0.42
Price$1.94
Change8.99%
Shares Out50.87M
Market Cap$98.69M
Enterprise Value$-19.29M
52W Range1.31 - 19.40
Beta0.93
P/E-1.52
P/B0.87
P/FCF-2.14
EV/EBITDA0.29
EV/FCF0.42
Earnings Yield-65.73%
FCF Yield-46.64%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio14.56
Quick Ratio14.56
Target$4.40
Target Upside126.80%
Target Median$4.00
Target Range4.00 - 5.00
Volume10.36M
Avg Volume1.03M
EPS Surprise0.05
Investment DNA
How strong this company looks for long-term investors
41
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
62/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 14.56Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 9 analyst votes · 2026-09-05
78/100
Bullish
Bullish
5
Hold
4
Bearish
0
Price Target
2026-08-14
Low
$4.00
Mean
$4.40
Median
$4.00
High
$5.00
Insider Transactions
Recent executive and insider activity
Giordano Christopher Thomas
Transaction: 07/13/2026
SELL
Change
-219
Price
$3.55
Filing
07/14/2026
Type
SELL
STAAB THOMAS R II
Transaction: 05/11/2026
OTHER
Change
0
Price
Not reported
Filing
05/13/2026
Type
OTHER
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Giordano Christopher Thomas | BUY | +219 | $3.55 | 07/13/2026 | 07/14/2026 |
| Giordano Christopher Thomas | SELL | -219 | $3.55 | 07/13/2026 | 07/14/2026 |
| STAAB THOMAS R II | OTHER | 0 | Not reported | 05/11/2026 | 05/13/2026 |
| STAAB THOMAS R II | BUY | +450,000 | $11.95 | 05/11/2026 | 05/13/2026 |
| MCGAULEY THOMAS | BUY | +50,000 | $12.51 | 01/30/2026 | 02/03/2026 |
| Hunter Robyn | BUY | +30,000 | $13.30 | 01/09/2026 | 01/13/2026 |
| Doogan Declan | BUY | +30,000 | $13.30 | 01/09/2026 | 01/13/2026 |
| Almenoff June Sherie | BUY | +30,000 | $13.30 | 01/09/2026 | 01/13/2026 |
| PROEHL GERALD T | BUY | +3,000 | $13.30 | 01/09/2026 | 01/13/2026 |
| Rich Stuart | BUY | +250,000 | $13.30 | 01/09/2026 | 01/13/2026 |
| Giordano Christopher Thomas | BUY | +450,000 | $13.30 | 01/09/2026 | 01/13/2026 |
| Davidson Michael H. | BUY | +30,000 | $13.30 | 01/09/2026 | 01/13/2026 |
| Rich Stuart | BUY | +2,500 | $10.22 | 12/09/2025 | 12/10/2025 |
| Rich Stuart | BUY | +2,500 | $10.10 | 12/08/2025 | 12/10/2025 |
| Rich Stuart | BUY | +2,500 | $9.20 | 12/04/2025 | 12/05/2025 |
| Rich Stuart | BUY | +1,500 | $9.08 | 12/03/2025 | 12/05/2025 |
| Rich Stuart | BUY | +1,000 | $9.01 | 12/02/2025 | 12/05/2025 |
| Giordano Christopher Thomas | BUY | +538 | $7.59 | 11/20/2025 | 11/20/2025 |
| Giordano Christopher Thomas | BUY | +455 | $7.51 | 11/19/2025 | 11/20/2025 |
| Giordano Christopher Thomas | BUY | +1,612 | $7.75 | 11/18/2025 | 11/20/2025 |